Evaluation and Management of Unilateral Nipple Discharge in a 33-Year-Old Woman on Depot Medroxyprogesterone Acetate
This patient requires imaging evaluation with diagnostic mammography and ultrasound to rule out pathologic causes, as unilateral nipple discharge is considered pathologic regardless of DMPA use.
Initial Clinical Assessment
First, determine if the discharge is physiologic or pathologic based on these specific features 1:
Pathologic discharge characteristics (requires imaging):
- Spontaneous (not provoked)
- Unilateral (as in this case)
- Single-duct orifice
- Serous or bloody
Physiologic discharge characteristics (no imaging needed):
- Provoked only
- Bilateral
- Multiple duct orifices
- White, green, or yellow color
Since this patient has unilateral discharge, it is pathologic by definition and warrants imaging evaluation 1, 2.
DMPA Considerations
While DMPA (depot medroxyprogesterone acetate) affects multiple hormonal parameters—decreasing plasma steroid levels, gonadotropins, and sex-hormone-binding-globulin 3—the FDA labeling does not list nipple discharge as a recognized side effect. Therefore, you cannot attribute unilateral nipple discharge to DMPA use and must proceed with full pathologic discharge workup.
Imaging Algorithm
For this 33-year-old patient with pathologic nipple discharge 1, 4:
First-line imaging: Diagnostic mammography PLUS targeted ultrasound
- At age 33, she falls into the 30-39 age range where ultrasound can be performed first, but diagnostic mammography should be added given the pathologic nature 4
- Both modalities are complementary and should be ordered together
If initial imaging is negative or inconclusive: Proceed to breast MRI
Malignancy Risk Context
The malignancy rate in pathologic nipple discharge ranges from 3-29%, with larger studies showing 11-16% risk 1. Even non-bloody discharge carries up to 12% malignancy risk 4. In one prospective study of unilateral discharge, malignancy was found in 4.4% of cases 5.
Critical point: Only 0.3% of women with non-spontaneous (provoked) discharge had carcinoma, versus significantly higher rates with spontaneous discharge 1.
Management Pathway
- If imaging shows a suspicious lesion: Refer to breast surgery for biopsy (core needle biopsy preferred over fine-needle aspiration) 2
- If imaging is completely negative including MRI: Surveillance is appropriate rather than automatic surgical excision 4
- Regarding DMPA: Continue or discontinue based on contraceptive needs, but do not assume it is the cause of unilateral discharge
Common Pitfalls to Avoid
- Do not dismiss unilateral discharge as "hormonal" from DMPA without proper imaging workup
- Do not order only ultrasound in this age group—diagnostic mammography adds critical information
- Do not proceed directly to surgery without completing the imaging algorithm, as most causes are benign (intraductal papilloma 35-48%, duct ectasia 17-36%) 1
- Do not rely on discharge cytology as it has poor positive predictive value (6.1-10.7%) and should not guide management 5
The key distinction is that physiologic discharge requires no imaging 1, but this patient's unilateral presentation mandates full evaluation regardless of her contraceptive method.